Results

Total Results: 628 records

Showing results for "prescribing".

81. CERs Report cover (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - Provider - barriers for physicians prescribing SERMs 4) Influences a. Social b. Economic c. … Studies of how clinicians are weighing the risks and benefits of prescribing medications to reduce … Studies of clinicians' attitudes towards prescribing non-medication-related interventions to reduce … Studies of patients' attitudes toward prescribing medications to reduce breast cancer risk. 66.7% … Given the inclination to provide positive responses (e.g. higher prescribing of SERMs), creative

82. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/adhd-medicines-risks/abstract

83. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - At the time of their approval, the prescribing information for both products stated that the drugs … Sovaldi (sofosbuvir) tablets, for oral use prescribing info. … Sovaldi (sofosbuvir) tablets, for oral use prescribing information. … Harvoni (ledipasvir and sofosbuvir) tablets, for oral use prescribing information. … Highlights of prescribing information: Daklinza (daclatasvir) tablets, for oral use.

84. Executive Summary: Systematic Review_Implementing Recommended Mental Health and Substance Use Screening and Counseling Interventions in Primary Care Settings for Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-executive-summary.pdf
    April 01, 2025 - counseling for moderate-risk and high- risk behaviors (addressing a positive screen), and appropriate prescribing … collaborative implementation may have little to no effect on increase in guideline-congruent ADHD prescribing … incorporation and learning collaborative implementation approach may increase guideline-congruent SSRI prescribing

85. App-E-Surv-Report-3-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
    October 08, 2025 - Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing

86. App-E-Surv-Report-2-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
    October 08, 2025 - Results, Function Results, QOL and Satisfaction with Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing

87. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
    May 01, 2008 - In other words, had practitioners followed the FDA labeling for prescribing cholinesterase inhibitors … Instead, we found that prescribing of these products in LTC settings was significantly higher among … The comparability of prescribing rates across the settings was also found despite the different method … The quality of antipsychotic drug prescribing in nursing homes.

88. Topic-Brief1-Care-Coordination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief1-care-coordination.pdf
    April 01, 2021 - found not having a usual provider versus having a usual provider was associated with high-risk opioid prescribing … Safe opioid prescribing for acute noncancer pain in hospitalized adults: a systematic review of existing

89. Topic-Brief1-Care-Coordination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
    April 01, 2021 - found not having a usual provider versus having a usual provider was associated with high-risk opioid prescribing … Safe opioid prescribing for acute noncancer pain in hospitalized adults: a systematic review of existing

90. Introduction (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
    February 01, 2009 - Although the precise reasons for DMARD prescribing preferences cannot be assessed in our study, these

91. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers of lorcaserin … The recommended prescribing by the manufacturer includes an initial low-titration dosage and a mid-titration … The drug has been classified by DEA as a Schedule IV drug; it became available for prescribing in June … Prescribing a medication and doing appropriate followup could provide clinicians an opportunity to … Prescribing information for Belviq (lorcaserin hydrochloride) tablets. [internet].

92. Alcohol-misuse-drug-therapy-140326 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
    January 27, 2012 - treatment, less than 1 in 10 receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these medications indicate that primary care providers are rarely using … Although primary care providers are proficient at prescribing a wide variety of medications, they generally … subject recruitment), interventions (e.g., dose and frequency of administration; type of provider prescribing … of enrolled populations; co-occurring disorders of enrolled populations; setting; type of provider prescribing

93. Hepatitis-C-Treatment-Adherence Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
    September 22, 2011 - whether they received therapeutic education from a third party (health care professional other than the prescribing

94. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Clinical Bottom Line (Continued) ALDH2 = aldehyde dehydrogenase 2 c The prescribing information sheet … Clinicians are advised to refer to the prescribing information sheet for additional information on adverse

95. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - abdominal pain.38 Other adverse events associated with azithromycin that could dissuade a physician from prescribing … KALYDECO (ivacaftor) tablets prescribing information. [internet]. … Zithromax (azithromycin tablets) and (azithromycin for oral suspension) prescribing information. … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf

96. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
    January 01, 2007 - A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing … or problems) 55.0 5.6 Physician consultation (contact with the patient’s primary care or other prescribing … Therapy tools and/or education for physicians (provision of patient-specific reports, physician prescribing

97. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0405_01-16-2011.pdf
    January 01, 2011 - Effective Health Care Topic Number: 0341 Document Completion Date: 3-23-11 1 Results of Topic Selection Process & Next Steps  Diagnosis and management of chronic cough will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparato…

98. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers of lorcaserin … The recommended prescribing by the manufacturer includes an initial low-titration dosage and a mid-titration … Drug Enforcement Administration as a Schedule IV drug; it became available for prescribing in June … IV drug (i.e., with a low potential for abuse and low risk of dependence); it became available for prescribing … Prescribing information for Belviq (lorcaserin hydrochloride) tablets. [internet].

99. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - What are the provider patterns of prescribing these medications, and what interventions are used to … support evidence-based decisionmaking about prescribing? … these medications, and of interventions used to support evidence-based decisionmaking about prescribing … What are the provider patterns of prescribing these medications, and what interventions are used to … support evidence-based decisionmaking about prescribing?

100. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - appropriate to list anti-sclerostin monoclonal antibody class-specific harms in Table 3 when the final prescribing … Prescribing Information, (06/2018). Cummings SR, Ferrari S, Eastell R et al. … I suggest that the committee carefully review the FDA-approved Prescribing Information for each product … Prescribing Information, (06/2018). 2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing Information, (06/2018).